Clinical Trial Update: Morphine Slow-release Capsules in Substitution Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating morphine slow-release capsules for substitution therapy in opiate-dependent individuals has completed. The sponsor listed is Mundipharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opiate Dependence

Drugs mentioned

• Morphine slow-release capsules (morphine sulfate, controlled-release)

Snippet

Sponsor: Mundipharma Medical Company | Conditions: Opiate Dependent | Phase 3 | Status: COMPLETED